Literature DB >> 12192469

Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia.

Gaku Okugawa1, Göran C Sedvall, Ingrid Agartz.   

Abstract

Magnetic resonance imaging (MRI) and tissue segmentation were used to quantify grey matter, white matter and cerebrospinal fluid (CSF) volumes in the brains of 32 males with chronic schizophrenia and 32 healthy males. Tissue volumes in the frontal, temporal, parietal, and occipital regions were measured separately. Males with schizophrenia had significant reductions of grey and white matter volumes in the temporal regions compared with controls. Patients also had significantly smaller white matter volumes in the cerebrum and increased CSF volumes in the frontal and the temporal regions as well as the cerebrum. The findings of the present study suggest that volumes of grey and white matter are reduced in the temporal region of males with chronic schizophrenia. The volume of white matter in the whole brain also appears to be reduced. Among the different brains regions, grey matter reduction was significant only in the temporal region.

Entities:  

Mesh:

Year:  2002        PMID: 12192469     DOI: 10.1007/s00406-002-0370-9

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  14 in total

1.  White matter volume abnormalities and associations with symptomatology in schizophrenia.

Authors:  Nikolaos Makris; Larry J Seidman; Todd Ahern; David N Kennedy; Verne S Caviness; Ming T Tsuang; Jill M Goldstein
Journal:  Psychiatry Res       Date:  2010-06-09       Impact factor: 3.222

Review 2.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

3.  Functional and anatomical connectivity abnormalities in left inferior frontal gyrus in schizophrenia.

Authors:  Bumseok Jeong; Cynthia G Wible; Ryu-ichiro Hashimoto; Marek Kubicki
Journal:  Hum Brain Mapp       Date:  2009-12       Impact factor: 5.038

Review 4.  Contribution of nonprimate animal models in understanding the etiology of schizophrenia.

Authors:  Noah L Lazar; Richard W J Neufeld; Donald P Cain
Journal:  J Psychiatry Neurosci       Date:  2011-07       Impact factor: 6.186

5.  Diffusion tensor imaging study of the middle cerebellar peduncles in patients with schizophrenia.

Authors:  Gaku Okugawa; Kenji Nobuhara; Tatsuya Sugimoto; Toshihiko Kinoshita
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

6.  Diffusion Imaging of White Matter In Schizophrenia: Progress and Future Directions.

Authors:  Katherine H Karlsgodt
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-05

Review 7.  Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?

Authors:  Andreas Konrad; Georg Winterer
Journal:  Schizophr Bull       Date:  2007-05-07       Impact factor: 9.306

8.  Frontal and temporal volume size of grey and white matter in patients with schizophrenia: an MRI parcellation study.

Authors:  Gaku Okugawa; Chiharu Tamagaki; Ingrid Agartz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-04-26       Impact factor: 5.270

9.  A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia.

Authors:  Serge A Mitelman; Adam M Brickman; Lina Shihabuddin; Randall E Newmark; Erin A Hazlett; M Mehmet Haznedar; Monte S Buchsbaum
Journal:  Neuroimage       Date:  2007-05-24       Impact factor: 6.556

10.  Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction.

Authors:  Linda Chang; Joseph Friedman; Thomas Ernst; Kai Zhong; Nicholas D Tsopelas; Kenneth Davis
Journal:  Biol Psychiatry       Date:  2007-08-13       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.